Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Antonio Palumbo(Azienda Ospedaliero Universitaria San Giovanni Battista), S. Vincent Rajkumar(Mayo Clinic), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Paul G. Richardson(Dana-Farber Cancer Institute), Jesús F. San Miguel(Complejo Hospitalario de Salamanca), Bart Barlogie(University of Arkansas for Medical Sciences), Jean‐Luc Harousseau(Hôtel-Dieu de Paris), Jeffrey A. Zonder(The Barbara Ann Karmanos Cancer Institute), Michèle Cavo(University of Bologna), Maurizio Zangari(University of Arkansas for Medical Sciences), Michel Attal(Hôpital Purpan), Andrew R. Belch, Stefan Knop(University of Tübingen), D. Joshua(Royal Prince Alfred Hospital), Orhan Sezer(Charité - Universitätsmedizin Berlin), Heinz Ludwig(Wilhelminen Hospital), David H. Vesole(Saint Vincent Health System), Joan Bladé(Universitat de Barcelona), Robert A. Kyle(Mayo Clinic in Arizona), Jan Westin(Lund University), Diane Weber(The University of Texas MD Anderson Cancer Center), Sara Bringhen(Azienda Ospedaliero Universitaria San Giovanni Battista), Rubén Niesvizky(Cornell University), Anders Waage(St Olav's University Hospital), Marie von Lilienfeld‐Toal(St James's University Hospital), Sagar Lonial(Emory University), Gareth J. Morgan(Institute of Cancer Research), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Kazuyuki Shimizu, Kenneth C. Anderson(Dana-Farber Cancer Institute), Mario Boccadoro(Azienda Ospedaliero Universitaria San Giovanni Battista), Brian G.M. Durie(Cedars-Sinai Medical Center), Pieter Sonneveld(Erasmus MC), M. A. Hussein(Cleveland Clinic), on behalf of the International Myeloma Working Group
Cited by 837
Abstract
Related Papers
No related papers found
Powered by citation graph analysis